Susceptibility of hepatoma-derived cells to histone deacetylase inhibitors is associated with ID2 expression

por TSUNEDOMI, RYOUICHI, IIZUKA, NORIO, HARADA, SAWAKO, OKA, MASAAKI
Publicado 2013

Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarray

por Tsunedomi, Ryouichi, Hazama, Shoichi, Okayama, Naoko, Oka, Masaaki, Nagano, Hiroaki
Publicado en Cancer Sci (2017)

Novel Biomarkers for Personalized Cancer Immunotherapy

por Shindo, Yoshitaro, Hazama, Shoichi, Tsunedomi, Ryouichi, Suzuki, Nobuaki, Nagano, Hiroaki
Publicado en Cancers (Basel) (2019)

The Activator of GntII Genes for Gluconate Metabolism, GntH, Exerts Negative Control of GntR-Regulated GntI Genes in Escherichia coli

por Tsunedomi, Ryouichi, Izu, Hanae, Kawai, Takuya, Matsushita, Kazunobu, Ferenci, Thomas, Yamada, Mamoru
Publicado 2003

Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs

por Hashimoto, Noriaki, Tsunedomi, Ryouichi, Yoshimura, Kiyoshi, Watanabe, Yusaku, Hazama, Shoichi, Oka, Masaaki
Publicado 2014

ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma

por TSUNEDOMI, RYOUICHI, IIZUKA, NORIO, YOSHIMURA, KIYOSHI, IIDA, MICHIHISA, TSUTSUI, MASAHITO, HASHIMOTO, NORIAKI, KANEKIYO, SHINSUKE, SAKAMOTO, KAZUHIKO, TAMESA, TAKAO, OKA, MASAAKI
Publicado 2013

Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts i...

por Ishiguro, Susumu, Yoshimura, Kiyoshi, Tsunedomi, Ryouichi, Oka, Masaaki, Takao, Sonshin, Inui, Makoto, Kawabata, Atsushi, Wall, Terrahn, Magafa, Vassiliki, Cordopatis, Paul, Tzakos, Andreas G, Tamura, Masaaki
Publicado en Cancer Biol Ther (2015)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations

por Maeda, Hiromichi, Hazama, Shoichi, Shavkat, Abdiev, Okamoto, Ken, Oba, Koji, Sakamoto, Junichi, Takahashi, Kenichi, Oka, Masaki, Nakamura, Daisuke, Tsunedomi, Ryouichi, Okayama, Naoko, Mishima, Hideyuki, Kobayashi, Michiya
Publicado 2014

A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome

por Hazama, Shoichi, Nakamura, Yusuke, Takenouchi, Hiroko, Suzuki, Nobuaki, Tsunedomi, Ryouichi, Inoue, Yuka, Tokuhisa, Yoshihiro, Iizuka, Norio, Yoshino, Shigefumi, Takeda, Kazuyoshi, Shinozaki, Hirokazu, Kamiya, Akira, Furukawa, Hiroyuki, Oka, Masaaki
Publicado 2014

Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer

por Inoue, Yuka, Hazama, Shoichi, Suzuki, Nobuaki, Tokumitsu, Yukio, Kanekiyo, Shinsuke, Tomochika, Shinobu, Tsunedomi, Ryouichi, Tokuhisa, Yoshihiro, Iida, Michihisa, Sakamoto, Kazuhiko, Takeda, Shigeru, Ueno, Tomio, Yoshino, Shigefumi, Nagano, Hiroaki
Publicado en Cancer Sci (2017)

Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two c...

por Maeda, Hiromichi, Hazama, Shoichi, Iwamoto, Shigeyoshi, Oba, Koji, Tsunedomi, Ryouichi, Okayama, Naoko, Suehiro, Yutaka, Yamasaki, Takahiro, Nakagami, Yuki, Suzuki, Nobuaki, Nagano, Hiroaki, Sakamoto, Junichi, Mishima, Hideyuki, Nagata, Naoki
Publicado en Oncol Lett (2019)

A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes

por TSUNEDOMI, RYOUICHI, HAZAMA, SHOICHI, FUJITA, YUSUKE, OKAYAMA, NAOKO, KANEKIYO, SHINSUKE, INOUE, YUKA, YOSHINO, SHIGEFUMI, YAMASAKI, TAKAHIRO, SUEHIRO, YUTA KA, OBA, KOJI, MISHIMA, HIDEYUKI, SAKAMOTO, JUNICHI, HAMAMOTO, YOSHIHIKO, OKA, MASAKI
Publicado 2014

Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture

por Usui, Tatsuya, Sakurai, Masashi, Umata, Koji, Elbadawy, Mohamed, Ohama, Takashi, Yamawaki, Hideyuki, Hazama, Shoichi, Takenouchi, Hiroko, Nakajima, Masao, Tsunedomi, Ryouichi, Suzuki, Nobuaki, Nagano, Hiroaki, Sato, Koichi, Kaneda, Masahiro, Sasaki, Kazuaki
Publicado en Int J Mol Sci (2018)

Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes

por Fujimoto, Takuya, Tsunedomi, Ryouichi, Matsukuma, Satoshi, Yoshimura, Kiyoshi, Oga, Atsunori, Fujiwara, Nobuyuki, Fujiwara, Yasuhiro, Matsui, Hiroto, Shindo, Yoshitaro, Tokumitsu, Yukio, Suzuki, Nobuaki, Kobayashi, Shogo, Hazama, Shoichi, Eguchi, Hidetoshi, Nagano, Hiroaki
Publicado en Oncol Lett (2021)

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma

por Yamamoto, Yoshiaki, Tsunedomi, Ryouichi, Fujita, Yusuke, Otori, Toru, Ohba, Mitsuyoshi, Kawai, Yoshihisa, Hirata, Hiroshi, Matsumoto, Hiroaki, Haginaka, Jun, Suzuki, Shigeo, Dahiya, Rajvir, Hamamoto, Yoshihiko, Matsuyama, Kenji, Hazama, Shoichi, Nagano, Hiroaki, Matsuyama, Hideyasu
Publicado en Oncotarget (2018)

Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer

por Kitahara, Masahiro, Hazama, Shoichi, Tsunedomi, Ryouichi, Takenouchi, Hiroko, Kanekiyo, Shinsuke, Inoue, Yuka, Nakajima, Masao, Tomochika, Shinobu, Tokuhisa, Yoshihiro, Iida, Michihisa, Sakamoto, Kazuhiko, Suzuki, Nobuaki, Takeda, Shigeru, Ueno, Tomio, Yamamoto, Shigeru, Yoshino, Shigefumi, Nagano, Hiroaki
Publicado en Cancer Sci (2016)

Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment

por Usui, Tatsuya, Sakurai, Masashi, Enjoji, Shuhei, Kawasaki, Hideyoshi, Umata, Koji, Ohama, Takashi, Fujiwara, Nobuyuki, Yabe, Ryotaro, Tsuji, Shunya, Yamawaki, Hideyuki, Hazama, Shoichi, Takenouchi, Hiroko, Nakajima, Masao, Tsunedomi, Ryouichi, Suzuki, Nobuaki, Nagano, Hiroaki, Sato, Koichi
Publicado en Stem Cells Int (2016)

MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer

por Kijima, Taiki, Hazama, Shoichi, Tsunedomi, Ryouichi, Tanaka, Hironori, Takenouchi, Hiroko, Kanekiyo, Shinsuke, Inoue, Yuka, Nakashima, Masao, Iida, Michihisa, Sakamoto, Kazuhiko, Suzuki, Nobuaki, Takeda, Shigeru, Ueno, Tomio, Yamamoto, Shigeru, Yoshino, Shigefumi, Okuno, Kiyotaka, Nagano, Hiroaki
Publicado en Oncol Rep (2017)

Metastatic ability and the epithelial‐mesenchymal transition in induced cancer stem‐like hepatoma cells

por Nishiyama, Mitsuo, Tsunedomi, Ryouichi, Yoshimura, Kiyoshi, Hashimoto, Noriaki, Matsukuma, Satoshi, Ogihara, Hiroyuki, Kanekiyo, Shinsuke, Iida, Michihisa, Sakamoto, Kazuhiko, Suzuki, Nobuaki, Takeda, Shigeru, Yamamoto, Shigeru, Yoshino, Shigefumi, Ueno, Tomio, Hamamoto, Yoshihiko, Hazama, Shoichi, Nagano, Hiroaki
Publicado en Cancer Sci (2018)

Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance

por Fujiwara, Yasuhiro, Tsunedomi, Ryouichi, Yoshimura, Kiyoshi, Matsukuma, Satoshi, Fujiwara, Nobuyuki, Nishiyama, Mitsuo, Kanekiyo, Shinsuke, Matsui, Hiroto, Shindo, Yoshitaro, Tokumitsu, Yukio, Yoshida, Shin, Iida, Michihisa, Suzuki, Nobuaki, Takeda, Shigeru, Ioka, Tatsuya, Hazama, Shoichi, Nagano, Hiroaki
Publicado en Pancreas (2021)